You could go with C50.919 – malignant neoplasm of unspecified site, of unspecified female breast. That is an option but a better and the best option is C79.81 – secondary malignant neoplasm of the breast. I’m going to now explain why that’s the best choice. There’s a coding note that I found that’s really worded well, so I took it from that site.
What is ICD-10-CM, ICD-10-PCS, CPT, and HCPCS?
Disclosures: Kuwahara reports serving as a CMS fellow and previously served as a fellow at the Association of Asian Pacific Community Health Organizations. Disclosures: Kuwahara reports serving as a CMS fellow and previously served as a fellow at the Association of Asian Pacific Community Health Organizations.
Currently, there is no requirement for ICD-10-PCS training. Cancer registrars who don't maintain AHIMA credentials don't need ICD-10-specific credit hours, but it is strongly recommended that they familiarize themselves with the code set. Unfortunately, medical coder classes likely are more in-depth than what's necessary for registrars.
Example: Patient is diagnosed with lower inner-quadrant right breast cancer in May. The ICD-9-CM code is 174.3 malignant, primary (ICD-10: C50. 311).
C50. 911 - Malignant neoplasm of unspecified site of right female breast | ICD-10-CM.
919 Malignant neoplasm of unspecified site of unspecified female breast.
C50. 912 - Malignant neoplasm of unspecified site of left female breast | ICD-10-CM.
ICD-10 code N63. 1 for Unspecified lump in the right breast is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
This year, the ICD-10 code N63, Lump in Breast has been expanded to a six-digit code which more specifically identifies the laterality and location of lumps with the breast area.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
2022 ICD-10-CM Diagnosis Code N63: Unspecified lump in breast.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
N64. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N64.
A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast.
Acquired absence of left breast and nipple The 2022 edition of ICD-10-CM Z90. 12 became effective on October 1, 2021.
3: Personal history of malignant neoplasm of breast.
Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
11.
Z85. 3 - Personal history of malignant neoplasm of breast. ICD-10-CM.
A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast.
An intraductal carcinoma of the breast extending to involve the nipple and areola, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells (paget's cells). (Dorland, 27th ed) Breast cancer affects one in eight women during their lives.
Breast self-exam and mammography can help find breast cancer early when it is most treatable. Treatment may consist of radiation, lumpectomy, mastectomy, chemotherapy and hormone therapy.men can have breast cancer, too, but the number of cases is small. nih: national cancer institute.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...